Abstract

Inosine triphosphatase (ITPA) is a ubiquitous key regulator of cellular non-canonical nucleotide levels. It breaks down inosine and xanthine nucleotides generated by deamination of purine bases. Its enzymatic action prevents accumulation of ITP and reduces the risk of incorporation of potentially mutagenic inosine nucleotides into nucleic acids. Here we describe the crystal structure of human ITPA in complex with its prime substrate ITP, as well as the apoenzyme at 2.8 and 1.1A, respectively. These structures show for the first time the site of substrate and Mg2+ coordination as well as the conformational changes accompanying substrate binding in this class of enzymes. Enzyme substrate interactions induce an extensive closure of the nucleotide binding grove, resulting in tight interactions with the base that explain the high substrate specificity of ITPA for inosine and xanthine over the canonical nucleotides. One of the dimer contact sites is made up by a loop that is involved in coordinating the metal ion in the active site. We predict that the ITPA deficiency mutation P32T leads to a shift of this loop that results in a disturbed affinity for nucleotides and/or a reduced catalytic activity in both monomers of the physiological dimer.

Highlights

  • The dataset obtained from trigonal crystals was not fully refined; see “Experimental Procedures” for a detailed explanation

  • This article cites 29 references, 2 of which can be accessed free at http://www.jbc.org/content/282/5/3182.full.html#ref-list-1

Read more

Summary

Crystal Structure of Human Inosine Triphosphatase

SUBSTRATE BINDING AND IMPLICATION OF THE INOSINE TRIPHOSPHATASE DEFICIENCY MUTATION P32T *. Inosine triphosphatase (ITPA) is a ubiquitous key regulator of cellular non-canonical nucleotide levels. It breaks down inosine and xanthine nucleotides generated by deamination of purine bases. We predict that the ITPA deficiency mutation P32T leads to a shift of this loop that results in a disturbed affinity for nucleotides and/or a reduced catalytic activity in both monomers of the physiological dimer. Triphosphates are present at low levels as byproducts generated either by deamination of purine bases or by phosphorylation of IMP. They are removed by the housecleaning enzyme inosine triphosphatase (ITP pyrophosphohydrolase; ITPase; ITPA4; EC 3.6.1.19) that catalyzes the conversion of inosine triphosphate (ITP) to IMP and pyrophosphate (PPi). The mode of substrate binding proposed could not account for the strong binding preference for ITP, dITP, and xanthine triphosphate over other nucleotides (2, 14)

Crystal Structure of Human ITPA
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
ITP complex
High resolution shell
Nordlund and Herwig Schüler
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call